Immix Biopharma (IMMX) Return on Capital Employed (2022 - 2026)

Quarterly results put Return on Capital Employed at 40.18% for Q1 2026, up 13953.0% from a year ago — trailing twelve months through Mar 2026 was 40.18% (up 13953.0% YoY), and the annual figure for FY2025 was 55.7%, up 12215.0%.

Immix Biopharma has reported Return on Capital Employed over the past 5 years, most recently at 40.18% for Q1 2026.

  • Return on Capital Employed reached 40.18% in Q1 2026 per IMMX's latest filing, up from 57.22% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 13.44% in Q1 2022 and bottomed at 343.22% in Q3 2025.
  • Median Return on Capital Employed over the past 5 years was 55.24% (2022), compared with a mean of 93.99%.
  • The largest annual shift saw Return on Capital Employed tumbled -28823bps in 2025 before it soared 13953bps in 2026.
  • Over 5 years, Return on Capital Employed stood at 55.24% in 2022, then skyrocketed by 55bps to 24.65% in 2023, then tumbled by -499bps to 147.64% in 2024, then soared by 61bps to 57.22% in 2025, then increased by 30bps to 40.18% in 2026.
  • Business Quant data shows Return on Capital Employed for IMMX at 40.18% in Q1 2026, 57.22% in Q4 2025, and 343.22% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 450.31%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 51.73%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -107.40%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 21.10%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 10.19%
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 20.34%
10 Immix Biopharma 476.17 Mn 476.17 Mn - -40.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -40.18%
Dec 31, 2025 -57.22%
Sep 30, 2025 -343.22%
Jun 30, 2025 -306.72%
Mar 31, 2025 -179.71%
Dec 31, 2024 -147.64%
Sep 30, 2024 -54.99%
Jun 30, 2024 -30.19%
Mar 31, 2024 -34.35%
Dec 31, 2023 -24.65%
Sep 30, 2023 -89.90%
Jun 30, 2023 -96.47%
Mar 31, 2023 -74.76%
Dec 31, 2022 -55.24%
Sep 30, 2022 -28.55%
Jun 30, 2022 -20.66%
Mar 31, 2022 -13.44%